Missouri Rep. Tony Lovasco (R) recently came through on his announced plan of filing a psychedelics bill with a revised measure that calls for legal psilocybin therapy for serious mental health cases, as first noted by Marijuana Moment.
The new house bill HB 869 would allow for psilocybin use in the treatment of PTSD, severe depression, terminal illness or mental health conditions for which traditional therapies have failed
Regulated by the Dept. of Health and Senior Services, the state agency is summoned to approve petitions adding a new condition for psilocybin therapy, provided evidence exists that it would benefit people suffering from that condition.
While it would not strictly legalize psilocybin, its possession (up to four grams) by patients and healthcare services providers would be decriminalized.
The proposal once included other psychedelics, but its sponsor eventually narrowed it down to psilocybin alone. Nonetheless, it is progressive in the sense that it proposes to expand patient access should the magic mushroom component be rescheduled or even descheduled on the federal Controlled Substances Act.
If so, adults over 21 could become eligible for psilocybin therapy if they can attest not having a condition for which the psychedelic holds any contraindications.
Lovasco is not alone on the quest for legal psilocybin therapy. In fact, psychedelics legalization seems to be a topic around which both parties are coming together, not just in Missouri but as a national trend.
Photo: Benzinga edit with photo by Eskymaks and Billion Photos on Shutterstock.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.